Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Hammer, Gregory B; Khanna, Ashish K; Michalsky, Cathy; Wase, Linda; Demitrack, Mark A; Little, Roderick; Fossler, Michael J; Ayad, Sabry

Hammer, Gregory B; Khanna, Ashish K; Michalsky, Cathy; Wase, Linda; Demitrack, Mark A; Little, Roderick; Fossler, Michael J; Ayad, Sabry.

Afiliación

Hammer GB; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94305-5640, USA. ham@stanford.edu.
Khanna AK; Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Michalsky C; Outcomes Research Consortium, Cleveland, OH, USA.
Wase L; Trevena Inc., Chesterbrook, PA, USA.
Demitrack MA; Trevena Inc., Chesterbrook, PA, USA.
Little R; Trevena Inc., Chesterbrook, PA, USA.
Fossler MJ; Department of Statistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Ayad S; Trevena Inc., Chesterbrook, PA, USA.

Pain Ther ; 10(2): 1343-1353, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34351590

Palabras clave

Adverse events; Logistic regression; Oliceridine; Opioid analgesic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pain Ther Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google